Adverse events related to total ankle replacement devices: an analysis of reports to the United States Food and Drug Administration

BACKGROUND: The published outcomes of total ankle replacement (TAR) implants came from limited institutions creating observational bias. For broader perspective, we queried the Food and Drug Administration’s (FDA) Manufacturer and User Facility Device Experience (MAUDE) voluntary database to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Karim, Metikala, Sreenivasulu, O’Connor, Kathryn M., Farber, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494697/
https://www.ncbi.nlm.nih.gov/pubmed/33575857
http://dx.doi.org/10.1007/s00264-021-04972-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494697/
https://www.ncbi.nlm.nih.gov/pubmed/33575857
http://dx.doi.org/10.1007/s00264-021-04972-z

Ejemplares similares